Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Neuroscientists from the University of Lausanne (UNIL) and the Wyss Center for Bio and Neuroengineering in Geneva have used a range of molecular, imaging and genetic tools to identify a new type of ...
- CANDID-CNS TM achieves an 83% success rate for predicting small molecule brain penetration and distribution versus a 64% success rate for the industry standard CNS-MPO score - Only ~2% of small ...
Breakthrough Therapy Designation is based on the encouraging survival data from the Phase 1 BrainChild-03 trial in children and young adults with diffuse intrinsic pontine glioma (DIPG) BrainChild Bio ...
TTUHSC’s Quentin R. Smith, Ph.D., and a team of researchers investigated methods to accurately measure drug permeability across the blood-brain barrier. For decades, scientists across the globe have ...
Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...
For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback